Takeda Pharmaceutical Company Limited American Depositary Receipt (TAK)
Market Closed
1 Sep, 20:00
$
18. 23
+0.25
+1.3904%
$
58.04B Market Cap
37.11 P/E Ratio
0.64% Div Yield
1.9M Volume
0 Eps
$ 17.98
Previous Close 
Want to track TAK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Takeda Pharmaceutical Company Limited American Depositary Receipt (TAK) Statistics
Valuation metrics
Market Cap 58.04B
Enterprise value 13.71T
Trailing P/E (ttm) 50.78
Forward P/E -
PEG ratio 1.65
Price/Sales (ttm) 2
Price/Book (mrq) 1.2
Enterprise Value/Revenue 2.97
Enterprise Value/EBITDA 10.9
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.04M
Average volume (90 days) 3.32M
Price summary
52-Week low 12.99
52-Week high 18.9
Beta -
50-Day moving average 17.51
200-Day moving average 17.47
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 100
Trailing annual dividend yield 0.0345%
5-Year annual dividend yield -
Payout ratio 1.75
Dividend Date 7 Jul 2025
Ex-Dividend Date 31 Mar 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.04%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1,477.99
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 57.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 168.82
Total debt (mrq) -
Total Debt/Equity (mrq) 0.65
Current ratio (mrq) 1.14%
Book value per share (mrq) 2,418.72
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
